Browse by Disease Classification

This page shows data for Hepatitic Disease Classification.
Total Entries Retrieved: 28
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10088 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Biogenetech Co. Ltd., Zhejiang Pukang Biotechnology Co. Ltd. 2010 Thailand 1.5 years and above Single dose Subcutaneous NA H2 strain of HAV H2-attenuated strain of HAV cultured in human diploid cells. China FDA, US FDA NA NA MEVAC-A 24280971 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/ https://apps.who.int/iris/bitstream/handle/10665/326501/97892516327-eng.pdf
10089 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Institute of Medical Biology, Chinese Academy of Medical Sciences NA China NA Single dose Subcutaneous NA H2 strain of HAV NA China FDA, US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Vaccine/U1DR1C1072530000811C-SPC.pdf
10090 HAVAC Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Changchun Institute of Biological Products NA China NA Single dose Subcutaneous NA LA-1 NA Government of Canada Changchun Changsheng Life Sciences NA NA 24280971 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/ https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
10091 HAVAC Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Changchun Institute of Biological Products NA China NA Single dose Subcutaneous NA LA-1 NA Government of Canada Changchun Changsheng Life Sciences NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
10092 HAVRIX Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA Belgium NA P: 720 EU; Adults: 1440 EU; 2 doses 0, 6–12 Intramuscular Aluminum (aluminium hydroxide) HM-175 NA US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert---HAVRIX.pdf
10093 VAQTA Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Merck & Co. Inc. NA USA NA P: 25 U; Adults: 50 U; 2 doses 0, 6–18 Intramuscular Aluminum (aluminium hydroxide) CR-326 NA US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.gov/vaccines-blood-biologics/vaccines/vaqta
10094 AVAXIM Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA Lyon, France NA P: 80 U; Adults: 160 U Intramuscular Aluminum (aluminium hydroxide) GBM NA US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Vaccine/U1DR1C1062460010911C-SPC.pdf
10095 Healive Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Sinovac Biotech Ltd. NA China NA P: 250 U; Adults: 500 U Intramuscular Aluminum (aluminium hydroxide) TZ-84 NA China FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ http://www.sinovac.com/news/shownews.php?id=764&lang=en
10096 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Institute of Medical Biology, Chinese Academy of Medical Sciences NA China NA P: 320 EU; Adults: 640 EU Intramuscular Aluminum (aluminium hydroxide) Lv-8 NA China FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482852/
10097 Veraxim Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Shanghai Wilson Bioengineering NA China NA P: 800 EU; Adults: 1600 EU Intramuscular Aluminum (aluminium hydroxide) YN-5 NA Government of China NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
10098 HAVRIX Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA Belgium 12 months and above Single dose for adult and 2 doses 6 to 12 months apart for infants Intramuscular NA NA NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine https://www.fda.gov/vaccines-blood-biologics/vaccines/havrix
10099 VAQTA Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Merck & Co. Inc. NA USA 12 months and above 2 doses 6 to 18 months apart Intramuscular NA NA NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine https://www.fda.gov/vaccines-blood-biologics/vaccines/vaqta
10100 TWINRIX Hepatitis A, Hepatitis B Hepatitic Hepatitis A, Hepatitis B virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA Rixensart, Belgium 18 years and above 3 doses at regimen of 0, 1, and 6 months Intramuscular Aluminum Strain HM175, HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine https://www.fda.gov/vaccines-blood-biologics/vaccines/twinrix
10101 ENGERIX-B Hepatitis B Hepatitic Hepatitis B virus double stranded DNA DNA based vaccine Approved GlaxoSmithKline NA Rixensart, Belgium All age group 3 doses at regimen of 0, 1, and 6 months Intramuscular NA HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/engerix-b
10102 RECOMBIVAX HB Hepatitis B Hepatitic Hepatitis B virus double stranded DNA Protein subunit Approved Merck & Co. Inc. NA USA All age group 2 doses 6 months apart Intramuscular NA HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/recombivax-hb
10103 HEPLISAV-B Hepatitis B Hepatitic Hepatitis B virus double stranded DNA Subunit vaccine Approved Dynavax NA NA 18 years and above 2 doses 1 month apart Intramuscular CpG HepB NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/heplisav-b
10104 PEDIARIX Hepatitis B, Diphtheria, Tetanus, Acellular pertussis , Poliomyelitis Hepatitic Hepatitis B virus double stranded DNA NA Approved GlaxoSmithKline NA USA 6 weeks - 7 years 2 doses 6 months apart Intramuscular NA HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/pediarix
10105 HBVaxPRO Hepatitis B Hepatitic Hepatitis B virus double stranded DNA Subunit vaccine Approved Sanofi Pasteur NA USA 18 years and above NA Intramuscular NA HBsAg NA EMA NA NA NA 26208678 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685678/ https://www.ema.europa.eu/en/documents/overview/hbvaxpro-epar-summary-public_en.pdf
10106 Fendrix Hepatitis B Hepatitic Hepatitis B virus double stranded DNA NA Approved GlaxoSmithKline NA Belgium NA NA Intradermal, Intravenous AS043 HBsAg NA US FDA NA NA NA 26208678 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685678/ https://www.ema.europa.eu/en/medicines/human/EPAR/fendrix
10107 Hecolin (Hepatitis vaccine -239) Hepatitis E Hepatitic Hepatitis E virus double stranded DNA Virus like particle Approved Xiamen Innovax Biotech 2011 China NA 3 doses at regimen of 0, 1, and 6 months Intramuscular NA HEV-1 Chinese strain NA China FDA NA NA NA 27610014 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988308/ https://www.precisionvaccinations.com/vaccines/hecolin-hepatitis-e-vaccine
10108 Hecolin (Hepatitis vaccine -239) Hepatitis E Hepatitic Hepatitis E virus double stranded DNA Recombinant viral vector Approved Xiamen Innovax Biotech 2011 China NA 3 doses at regimen of 0, 1, and 6 months Intramuscular Aluminum (aluminium hydroxide) Capsid Protein ORF2 NA China FDA NA NA Hecolin 29546064 NCT01014845 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818934/ https://www.precisionvaccinations.com/vaccines/hecolin-hepatitis-e-vaccine
10109 AMBIRIX Hepatitis A, Hepatitis B Hepatitic Hepatitis A, Hepatitis B virus double stranded DNA Inactivated Approved GlaxoSmithKline 2002 Belgium 1 - 15 years 2 doses 6 to 12 months apart Intramuscular Aluminum (aluminium hydroxide) Inactivated hepatitis A virus and surface antigen of hepatitis B virus Produced on human diploid (MRC-5) cells EMA NA NA NA NA NA https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf
10110 AMBIRIX Hepatitis A, Hepatitis B Hepatitic Hepatitis A, Hepatitis B virus double stranded DNA Inactivated Approved GlaxoSmithKline 2002 Belgium 2 - 15 years 2 doses 6 to 12 months apart Intramuscular Aluminum (aluminum phosphate) Inactivated hepatitis A virus and surface antigen of hepatitis B virus Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology EMA NA NA NA NA NA https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf
10111 VIVAXIM Hepatitis A, Typhoid Hepatitic Hepatitis A virus, Salmonella typhi double stranded DNA NA Approved Sanofi Pasteur 2007 France 16 years and above Single dose Intramuscular Aluminum (aluminium hydroxide) Salmonella typhi Vi polysaccharide (Ty 2 strain) and formaldehyde inactivated hepatitis A virus antigen (GBM strain) GBM strain cultured on MRC-5 human diploid cells Government of Canada NA NA VIATIM NA NA http://products.sanofi.com.au/vaccines/VIVAXIM_NZ_PI.pdf https://pdf.hres.ca/dpd_pm/00032177.PDF
10296 rHEV Hepatitis E Hepatitic Hepatitis E virus double stranded DNA Recombinant viral vector Phase 2 GlaxoSmithKline 2011 USA 18 - 58 years 3 doses at regimen of 0, 1, and 6 months NA Aluminum (alum) Capsid Protein ORF2 NA NA National Institute of Health, Novavax NA NA NA NA https://www.who.int/immunization/sage/meetings/2014/october/4_Hepatitis_E_vaccine_pipeline_final_29_Sept_14.pdf NA
10366 EPAXAL Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Phase 3 Crucell, Berna Biotech NA Berne, Switzerland NA P: 24 U; Adults: 24 U Intramuscular NA RG-SB NA NA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ NA
10367 Aimugen Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Phase 3 Chemo-Sero-Therapeutic Research Institute NA Japan NA P: 0.5 µg; Adults: 0.5 µg Intramuscular Aluminum (aluminium hydroxide) KRM003 NA NA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ NA
10368 Hepatyrix Hepatitis A, Typhoid Hepatitic Hepatitis A virus, Salmonella typhi double stranded DNA Inactivated Phase 3 Sanofi Pasteur 2015 Belgium 15 years and above Single dose Intramuscular NA Hepatitis A viral protein along with Vi polysaccharide antigen (a part of the Salmonella typhi (Ty2 strain) bacterium NA NA NA NA NA NA NA https://www.hpra.ie/img/uploaded/vaccines/PIL_PA1077099001.pdf NA